The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Caverject 20 micrograms Powder and Solvent for Solution for Injection

Pfizer Healthcare IrelandPA0822/115/003

Main Information

Trade NameCaverject 20 micrograms Powder and Solvent for Solution for Injection
Active SubstancesAlprostadil
Dosage FormPowder and solvent for solution for injection
Licence HolderPfizer Healthcare Ireland
Licence NumberPA0822/115/003

Group Information

ATC CodeG04BE Drugs used in erectile dysfunction
G04BE01 alprostadil


License statusAuthorised
Licence Issued13/03/1995
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceNone
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back